FDA Finally Moves on Breast Density

After a long wait, the FDA issued a final rule that adds details on breast density reporting to the Mammography Quality Standards Act. The rule takes effect in September 2024 and should go a long way toward clarifying the issue of breast density for patients. 

Breast tissue density is a risk factor for cancer, and dense breast tissue can make it more difficult for radiologists to identify tumors on conventional x-ray mammography. This shortcoming is often not communicated to women who receive “normal” mammograms, but later find out that a cancer was missed.

Prodded by a strong patient advocacy movement, individual states have been passing laws requiring women to be notified of their density status, creating a patchwork of regulation across the U.S. 

The FDA in 2018 agreed to set a national standard by rolling breast density reporting into an update of the MQSA. But the long wait has frustrated many in the breast density advocacy movement.

There are several major components to the new rule, which: 

  • Requires breast imaging facilities to provide patients with a summary of the mammography report written in lay terms that identifies whether patients have dense or non-dense breast tissue.
  • Instructs facilities to include a section in the mammography report explaining the significance of breast density. 
  • Establishes four categories for reporting breast tissue density in the mammography report. 
  • Sets the specific language to be used for reporting density. 

The new rules provide much-needed national consistency in breast density reporting, and will replace the patchwork of state regulation that has developed over the years. Developers of breast density software may also benefit from the new federal rules, as they simplify the number of regulations that need to be tracked. 

The Takeaway

Better late than never. While the FDA should have signed off on this years ago, now that the rules are issued the breast imaging community can move ahead with integrating them into clinical practice. The new rules should also help density reporting software developers by setting a national standard rather than a patchwork of state regulation. 

ECR 2023 Bounces Back As AI Tops Clinical Program

The European Congress of Radiology is back. European radiologists returned to Vienna in force last week for ECR 2023, surprising many naysayers with crowded presentation rooms and exhibit booths.

Due to the COVID-19 pandemic, it was the first ECR meeting since 2019 to be held in the conference’s traditional timeframe of early March. And after a lightly attended ECR 2022, held during Europe’s July vacation season, many were watching with bated breath to see if the conference could mount a comeback. 

Fortunately, ECR 2023 didn’t disappoint. While attendance didn’t hit the high water mark set prior to the pandemic, it was strong enough to satisfy most that the show was indeed healthy, with chatter on-site placing attendance at around 17,000.

As with RSNA 2022, interest in AI was strong. AI-based content permeated the scientific sessions as well as the exhibit floor, and the show’s AI Theatre was packed for nearly every presentation. 

In his opening address, ECR 2023 President Dr. Adrian Brady of Ireland addressed concerns about AI’s impact on radiology in the years to come, characterizing it as one of the “winds of change” that should be embraced rather than shunned. 

Other major trends at ECR 2023 included: 

Patient Safety – Many sessions discussed how to reduce risk when scanning patients, ranging from lowering radiation dose to limiting the amount of contrast media to MRI scanning of patients with metallic implants.

Sustainability – Energy challenges have gripped the European continent since the Russian invasion of Ukraine in 2022, and imaging energy conservation was a key focus across several sessions. 

Workhorse Modalities – Unlike RSNA, where new product launches were focused on high-end premium systems, scanner introductions at ECR 2023 concentrated on workhorse offerings like mid-range CT and 1.5-tesla MRI.

The Takeaway

ECR is indeed back. It may not yet be a mandatory show for most U.S. radiologists, but it has regained its importance for anyone interested in a more global look at medical imaging. And given the European emphasis on research, it’s a great place to learn about new technologies before they appear in North America.

Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Imaging Wire team

You're all set!